AIM ImmunoTech Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
AIM ImmunoTech Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • AIM ImmunoTech Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 57.1M shares, a 18% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 57.1M +8.72M +18% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 50.3M +1.84M +3.81% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 49.1M +1.02M +2.12% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 48.8M +715K +1.49% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 48.4M +371K +0.77% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 48.4M +413K +0.86% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 48.1M +89.6K +0.19% Dec 31, 2022 10-K 2024-04-01
Q3 2022 48.1M +234K +0.49% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 48M +216K +0.45% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 48M +162K +0.34% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 48M +5.84M +13.9% Dec 31, 2021 10-K 2023-03-31
Q3 2021 47.8M +7.16M +17.6% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 47.8M +13.6M +39.7% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 47.8M +19.8M +70.5% Mar 31, 2021 10-Q 2021-08-16
Q4 2020 42.2M +31.8M +306% Dec 31, 2020 10-K 2022-03-31
Q3 2020 40.7M +34.6M +567% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 34.3M +32M +1446% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 28.1M -34.8M -55.4% Mar 31, 2020 10-Q/A 2020-05-14
Q4 2019 10.4M +9.28M +838% Dec 31, 2019 10-K 2021-03-31
Q3 2019 6.1M -41.9M -87.3% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 2.21M -44.6M -95.3% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 62.9M +23.7M +60.4% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 1.11M -31.8M -96.6% Dec 31, 2018 10-K 2020-03-30
Q3 2018 48M +16.9M +54.3% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 46.8M +17.9M +61.7% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 39.2M +13M +49.8% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 32.9M +8.68M +35.9% Dec 31, 2017 10-K 2019-04-01
Q3 2017 31.1M +6.97M +28.9% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 29M -220M -88.4% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 26.2M -221M -89.4% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 24.2M +3.57M +17.3% Dec 31, 2016 10-K 2018-03-30
Q3 2016 24.1M -223M -90.3% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 249M +3.35M +1.36% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 248M +21.8M +9.67% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 20.6M -183M -89.9% Dec 31, 2015 10-K 2017-03-31
Q3 2015 248M +53.8M +27.8% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 245M +56M +29.5% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 226M +42.5M +23.2% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 204M +35.3M +21% Dec 31, 2014 10-K 2016-03-29
Q3 2014 194M +26.2M +15.6% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 189M +22.3M +13.3% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 183M +16.2M +9.7% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 169M +2.17M +1.3% Dec 31, 2013 10-K 2015-03-19
Q3 2013 168M +20M +13.6% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 167M +31M +22.8% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 167M +31.2M +23% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 166M +30.8M +22.7% Dec 31, 2012 10-K 2014-03-14
Q3 2012 148M +12M +8.83% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 136M +762K +0.56% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 136M Mar 31, 2012 10-Q 2012-05-07
Q4 2011 136M +401K +0.3% Dec 31, 2011 10-K 2013-03-18
Q3 2011 136M Sep 30, 2011 10-Q 2011-11-09
Q2 2011 135M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 135M Dec 31, 2010 10-K 2012-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.